{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:29:32Z","timestamp":1792787372172,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Parkinson's UK","award":["H-0902"],"award-info":[{"award-number":["H-0902"]}],"id":[{"id":"https:\/\/ror.org\/02417p338","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004815","name":"The Isaac Newton Trust","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004815","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000727","name":"Trinity College Cambridge","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000727","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.neuropharm.2013.05.013","type":"journal-article","created":{"date-parts":[[2013,5,28]],"date-time":"2013-05-28T22:37:31Z","timestamp":1369780651000},"page":"138-146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Memantine block depends on agonist presentation at the NMDA receptor in substantia nigra pars compacta dopamine neurones"],"prefix":"10.1016","volume":"73","author":[{"given":"A.R.","family":"Wild","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Akyol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.L.C.","family":"Brothwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Kimkool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.N.","family":"Skepper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.J.","family":"Gibb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.neuropharm.2013.05.013_bib1","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/0896-6273(95)90186-8","article-title":"Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function","volume":"15","author":"Ankarcrona","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2013.05.013_bib2","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0006-8993(92)90645-P","article-title":"Glutamate stimulation of tyrosine hydroxylase is mediated by NMDA receptors in the rat striatum","volume":"569","author":"Arias-Monta\u00f1o","year":"1992","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.neuropharm.2013.05.013_bib3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0301-0082(99)00067-2","article-title":"Functional changes of the basal ganglia circuitry in Parkinson's disease","volume":"62","author":"Blandini","year":"2000","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2013.05.013_bib4","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1152\/jn.1997.77.1.309","article-title":"Trapping channel block of NMDA-activated responses by amantadine and memantine","volume":"77","author":"Blanpied","year":"1997","journal-title":"J.\u00a0Neurophysiol."},{"key":"10.1016\/j.neuropharm.2013.05.013_bib5","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1471-4159.2004.02550.x","article-title":"Phosphorylation of Ser19 increases both Ser40 phosphorylation and enzyme activity of tyrosine hydroxylase in intact cells","volume":"90","author":"Bobrovskaya","year":"2004","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2013.05.013_bib6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1476-5381.1996.tb15971.x","article-title":"Effects of memantine on recombinant rat NMDA receptors expressed in HEK 293 cells","volume":"119","author":"Bresink","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.05.013_bib7","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1113\/jphysiol.2007.144618","article-title":"NR2B- and NR2D-containing synaptic NMDA receptors in developing rat substantia nigra pars compacta dopaminergic neurones","volume":"586","author":"Brothwell","year":"2008","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2013.05.013_bib8","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1006\/exnr.2000.7310","article-title":"Differential vulnerabilities of substantia nigra catecholamine neurons to excitatory amino acid-induced degeneration in rat midbrain slices","volume":"162","author":"Bywood","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2013.05.013_bib9","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1111\/j.1471-4159.2006.03991.x","article-title":"The chemical biology of clinically tolerated NMDA receptor antagonists","volume":"97","author":"Chen","year":"2006","journal-title":"J.\u00a0Neurochem."},{"issue":"Pt 1","key":"10.1016\/j.neuropharm.2013.05.013_bib10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1113\/jphysiol.1997.sp021909","article-title":"Mechanism of memantine block of NMDA-activated channels in rat retinal ganglion cells: uncompetitive antagonism","volume":"499","author":"Chen","year":"1997","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2013.05.013_bib11","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0306-4522(98)00163-8","article-title":"Neuroprotective concentrations of the N-methyl-D-aspartate open-channel blocker memantine are effective without cytoplasmic vacuolation following post-ischemic administration and do not block maze learning or long-term potentiation","volume":"86","author":"Chen","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2013.05.013_bib12","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1111\/j.1471-4159.1991.tb02081.x","article-title":"Presynaptic adenosine A2 and N-methyl-D-aspartate receptors regulate dopamine synthesis in rat striatal synaptosomes","volume":"56","author":"Chowdhury","year":"1991","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2013.05.013_bib13","first-page":"re16","article-title":"Role of distinct NMDA receptor subtypes at central synapses","volume":"255","author":"Cull-Candy","year":"2004","journal-title":"Sci. STKE"},{"key":"10.1016\/j.neuropharm.2013.05.013_bib14","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0149-7634(96)00037-1","article-title":"Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents \u2013 preclinical studies","volume":"21","author":"Danysz","year":"1997","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2013.05.013_bib15","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s007260070045","article-title":"NMDA channel blockers: memantine and amino-aklylcyclohexanes \u2013 in\u00a0vivo characterization","volume":"19","author":"Danysz","year":"2000","journal-title":"Amino Acids"},{"key":"10.1016\/j.neuropharm.2013.05.013_bib16","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0006-8993(94)91874-0","article-title":"Opposite presynaptic regulations by glutamate through NMDA receptors of dopamine synthesis and release in rat striatal synaptosomes","volume":"640","author":"Desce","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2013.05.013_bib17","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0163-7258(98)00042-4","article-title":"The role of excitotoxicity in neurodegenerative disease: implications for therapy","volume":"81","author":"Doble","year":"1999","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2013.05.013_bib18","series-title":"The Rat Nervous System","article-title":"Substantia nigra","author":"Fallon","year":"1995"},{"key":"10.1016\/j.neuropharm.2013.05.013_bib19","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1476-5381.1996.tb15245.x","article-title":"Effects of memantine and MK-801 on NMDA-induced currents in cultured neurones and on synaptic transmission and LTP in area CA1 of rat hippocampal slices","volume":"117","author":"Frankiewicz","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.05.013_bib20","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.neuropharm.2007.05.022","article-title":"Agonist concentration dependency of blocking kinetics but not equilibrium block of N-methyl-D-aspartate receptors by memantine","volume":"53","author":"Gilling","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2013.05.013_bib21","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0306-4522(96)00473-3","article-title":"Slowly triggered excitotoxicity occurs by necrosis in cortical cultures","volume":"77","author":"Gwag","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2013.05.013_bib22","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.pharmthera.2004.04.001","article-title":"Rationale for and use of NMDA receptor antagonists in Parkinson\u2019s disease","volume":"102","author":"Hallett","year":"2004","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2013.05.013_bib23","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nrn2911","article-title":"Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders","volume":"11","author":"Hardingham","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2013.05.013_bib24","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nn835","article-title":"Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways","volume":"5","author":"Hardingham","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2013.05.013_bib25","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1523\/JNEUROSCI.13-05-01993.1993","article-title":"Glutamate receptor-induced 45Ca2+ accumulation in cortical cell culture correlates with subsequent neuronal degeneration","volume":"13","author":"Hartley","year":"1993","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2013.05.013_bib26","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1023\/A:1018856020583","article-title":"Brain penetration and in\u00a0vivo recovery of NMDA receptor antagonists amantadine and memantine: a quantitative microdialysis study","volume":"16","author":"Hesselink","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.neuropharm.2013.05.013_bib27","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/nn.2368","article-title":"Cholinergic modulation of multivesicular release regulates striatal synaptic potency and integration","volume":"12","author":"Higley","year":"2009","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2013.05.013_bib28","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/ana.410440407","article-title":"Neurophysiological identification of the subthalamic nucleus in surgery for Parkinson's disease","volume":"44","author":"Hutchison","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2013.05.013_bib29","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1006\/exnr.1998.6783","article-title":"Excitatory amino acid-induced degeneration of dendrites of catecholamine neurons in rat substantia nigra","volume":"151","author":"Johnson","year":"1998","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2013.05.013_bib30","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.coph.2005.09.007","article-title":"Mechanism of action of memantine","volume":"6","author":"Johnson","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.05.013_bib31","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1113\/jphysiol.2005.095554","article-title":"Functional NR2B- and NR2D-containing NMDA receptor channels in rat substantia nigra dopaminergic neurones","volume":"569","author":"Jones","year":"2005","journal-title":"J.\u00a0Physiol."},{"issue":"3","key":"10.1016\/j.neuropharm.2013.05.013_bib32","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1124\/mol.61.3.533","article-title":"Channel blockers acting at N-methyl-D-aspartate receptors: differential effects of mutations in the vestibule and ion channel pore","volume":"61","author":"Kashiwagi","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.05.013_bib33","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/nn936","article-title":"NMDA receptor pathways as drug targets","volume":"5","author":"Kemp","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2013.05.013_bib34","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1523\/JNEUROSCI.3703-08.2009","article-title":"Mg2+ imparts NMDA receptor subtype selectivity to the Alzheimer's drug memantine","volume":"29","author":"Kotermanski","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2013.05.013_bib35","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","article-title":"Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses","volume":"51","author":"Krystal","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2013.05.013_bib36","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nrn2153","article-title":"NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders","volume":"8","author":"Lau","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2013.05.013_bib37","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1602\/neurorx.1.1.101","article-title":"Failures and successes of NMDA receptor antagonists: molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insults","volume":"1","author":"Lipton","year":"2004","journal-title":"NeuroRx"},{"key":"10.1016\/j.neuropharm.2013.05.013_bib38","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/nrd1958","article-title":"Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond","volume":"5","author":"Lipton","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2013.05.013_bib39","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nrn2229","article-title":"Pathologically activated therapeutics for neuroprotection","volume":"8","author":"Lipton","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2013.05.013_bib40","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrn2191","article-title":"The sequence of events that underlie quantal transmission at central glutamatergic synapses","volume":"8","author":"Lisman","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2013.05.013_bib41","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s11055-009-9244-1","article-title":"Use of memantine (akatinol) for the correction of cognitive impairments in Parkinson's disease complicated by dementia","volume":"40","author":"Litvinenko","year":"2010","journal-title":"Neurosci. Behav. Physiol."},{"key":"10.1016\/j.neuropharm.2013.05.013_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5414\/CPP42001","article-title":"Review of NMDA antagonist-induced neurotoxicity and implications for clinical development","volume":"42","author":"Low","year":"2004","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2013.05.013_bib43","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1113\/jphysiol.1991.sp018396","article-title":"Actions of ketamine, phencyclidine and MK-801 on NMDA receptor currents in cultured mouse hippocampal neurones","volume":"432","author":"MacDonald","year":"1991","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2013.05.013_bib44","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1046\/j.1460-9568.2000.00127.x","article-title":"Subthalamic neuron activity related to tremor and movement in Parkinson's disease","volume":"12","author":"Magari\u00f1os-Ascone","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2013.05.013_bib45","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0306-4522(99)00583-7","article-title":"Single-unit analysis of the pallidum, thalamus and subthalamic nucleus in parkinsonian patients","volume":"96","author":"Magnin","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2013.05.013_bib46","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1113\/jphysiol.2006.117069","article-title":"The ventral tegmental area revisited: is there an electrophysiological marker for dopaminergic neurons?","volume":"577","author":"Margolis","year":"2006","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2013.05.013_bib47","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.neuro.2012.04.006","article-title":"NMDA alters rotenone toxicity in rat substantia nigra zona compacta and ventral tegmental area dopamine neurons","volume":"33","author":"Munhall","year":"2012","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuropharm.2013.05.013_bib48","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1523\/JNEUROSCI.22-04-01290.2002","article-title":"I(h) channels contribute to the different functional properties of identified dopaminergic subpopulations in the midbrain","volume":"22","author":"Neuhoff","year":"2002","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2013.05.013_bib49","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.neuropharm.2010.10.008","article-title":"Quantification of the Mg2+-induced potency shift of amantadine and memantine voltage-dependent block in human recombinant GluN1\/GluN2A NMDARs","volume":"60","author":"Otton","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2013.05.013_bib50","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/nn2071","article-title":"Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses","volume":"11","author":"Papadia","year":"2008","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2013.05.013_bib51","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1007\/s00702-008-0087-7","article-title":"Blocking kinetics of memantine on NR1a\/2A receptors recorded in inside-out and outside-out patches from Xenopus oocytes","volume":"115","author":"Parsons","year":"2008","journal-title":"J.\u00a0Neural Transm."},{"key":"10.1016\/j.neuropharm.2013.05.013_bib52","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.neuropharm.2007.07.013","article-title":"Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system \u2013 too little activation is bad, too much is even worse","volume":"53","author":"Parsons","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2013.05.013_bib53","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/ana.22222","article-title":"Subthalamic neuronal firing in obsessive\u2013compulsive disorder and Parkinson disease","volume":"69","author":"Piallat","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2013.05.013_bib54","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1192\/bjp.bp.105.015263","article-title":"Psychological effects of ketamine in healthy volunteers. Phenomenological study","volume":"189","author":"Pomarol-Clotet","year":"2006","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2013.05.013_bib55","first-page":"93","article-title":"Akatinol memantine in the therapy of cognitive disorders in Parkinson's disease","volume":"95","author":"Puzin","year":"2007","journal-title":"Zh. Nevrol. Psikhiatr. Im. S. S. Korsakova"},{"key":"10.1016\/j.neuropharm.2013.05.013_bib56","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/BF02260076","article-title":"Efficacy of memantine, an NMDA receptor antagonist, in the treatment of Parkinson's disease","volume":"4","author":"Rabey","year":"1992","journal-title":"J.\u00a0Neural Transm. Park. Dis. Dement. Sect."},{"key":"10.1016\/j.neuropharm.2013.05.013_bib57","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0304-3940(97)00936-1","article-title":"Glutamate neurotoxicity in mouse cortical neurons: atypical necrosis with DNA ladders and chromatin condensation","volume":"240","author":"Sohn","year":"1998","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2013.05.013_bib58","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1152\/jn.90574.2008","article-title":"Neuronal activity of the human subthalamic nucleus in the parkinsonian and nonparkinsonian state","volume":"100","author":"Steigerwald","year":"2008","journal-title":"J.\u00a0Neurophysiol."},{"key":"10.1016\/j.neuropharm.2013.05.013_bib59","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1460-9568.2010.07298.x","article-title":"Functional heterogeneity of NMDA receptors in rat substantia nigra pars compacta and reticulata neurones","volume":"32","author":"Su\u00e1rez","year":"2010","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2013.05.013_bib60","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1111\/j.1460-9568.2006.04787.x","article-title":"Neuroprotective properties of memantine in different in\u00a0vitro and in\u00a0vivo models of excitotoxicity","volume":"23","author":"Volbracht","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2013.05.013_bib61","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00008877-200305000-00007","article-title":"Role of the NMDA receptor NR2B subunit in the discriminative stimulus effects of ketamine","volume":"14","author":"De Vry","year":"2003","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.05.013_bib62","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0168-0102(99)00039-5","article-title":"Early postnatal development of substantia nigra neurons in rat midbrain slices: hyperpolarization-activated inward current and dopamine-activated current","volume":"34","author":"Washio","year":"1999","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2013.05.013_bib63","first-page":"205","article-title":"Blockade of NMDA receptors in postnatal period decreased density of tyrosine hydroxylase immunoreactive axonal arbors in the medial prefrontal cortex of adult rats","volume":"56","author":"Wedzony","year":"2005","journal-title":"J.\u00a0Physiol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.05.013_bib64","doi-asserted-by":"crossref","first-page":"6732","DOI":"10.1523\/JNEUROSCI.6371-11.2012","article-title":"Synaptic NMDA receptors mediate hypoxic excitotoxic death","volume":"32","author":"Wroge","year":"2012","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2013.05.013_bib65","doi-asserted-by":"crossref","first-page":"11246","DOI":"10.1523\/JNEUROSCI.2488-10.2010","article-title":"Memantine preferentially blocks extrasynaptic over synaptic NMDA receptor currents in hippocampal autapses","volume":"30","author":"Xia","year":"2010","journal-title":"J.\u00a0Neurosci."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390813002232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390813002232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,14]],"date-time":"2019-07-14T02:18:27Z","timestamp":1563070707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390813002232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":65,"alternative-id":["S0028390813002232"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2013.05.013","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Memantine block depends on agonist presentation at the NMDA receptor in substantia nigra pars compacta dopamine neurones","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2013.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}